Platform
Features
1 follower
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.
Industries
Headquarters
Employees
Links
10 members
7 members
3 members
Calico
6 followers
Tessera Therapeutics
2 followers
Septerna
Vera Therapeutics
89bio
Neogene Therapeutics
Protein Metrics
Day One Biopharmaceuticals
Cargo
Capricor Therapeutics
PMV Pharmaceuticals
Explore companies